Biotech

All Articles

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.OS Therapies will note on the NYSE American supply exchange this morning by means of a $6.4 thousan...

ALX's waning CD47 reaction price sends inventory spiraling down

.ALX Oncology's stage 2 gastric cancer cells action fee has weakened. After finding its own CD47 blo...

Ionis centers eye condition coming from intendeds of Roche-partnered prospect after information let down

.Another of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed expectation...

Biogen's chief executive officer mentioned no risky sell 2023. He's ready to be strong

.While Biogen's pharma peers are actually seeking for late-stage properties along with little threat...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Bio has actually been a biotech trying to find a pipe after it junked its lead possessions o...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored civil rights to a very early Alzheimer's condition system to Denali Re...

Takeda faucets brand new mind people oncology company-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable management hirings, shootings and als...

Vertex, beaten by AATD once again, falls 2 assets on throw away pile

.Tip's attempt to alleviate a rare hereditary condition has attacked yet another problem. The biotec...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Biotechnology's second-quarter earnings record wasn't except big information. The business welc...

Galapagos stops CAR-T cell treatment litigation over Parkinsonism instance

.Galapagos has actually stopped registration in a trial of a BCMA-directed CAR-T tissue treatment, p...